Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of a Multiplexed Molecular Biomarker Test Cxbladder, in Real World Decision Making to Provide Clinical Utility Using a Randomized Design ("STRATA Study")

NCT03988309 is registered in ClinicalTrials.gov with Pacific Edge Limited as lead sponsor.

NCT NCT03988309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03988309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of a Multiplexed Molecular Biomarker Test Cxbladder, in Real World Decision Making to Provide Clinical Utility Using a Randomized Design ("STRATA Study")
Lead sponsor
Pacific Edge Limited
Phase
Not applicable
Overall status
Completed
Start date
September 11, 2019
Completion date
July 24, 2024
Enrollment
554 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

hematuria, urothelial carcinoma